Beating CAEBV with a New Weapon: Glycoprotein 350-Targeted T-Cell Therapy
Imagine living with a virus that never goes away. That's what people with Chronic Active Epstein-Barr Virus (CAEBV) infection experience. This infection, though rare, is serious. The Epstein-Barr virus (EBV) sticks around, causing symptoms and even life-threatening problems. Doctors are still figuri